Literature DB >> 22632385

Motivational interviewing and cognitive behaviour therapy for anxiety following traumatic brain injury: a pilot randomised controlled trial.

Ming-Yun Hsieh1, Jennie Ponsford, Dana Wong, Michael Schönberger, John Taffe, Adam McKay.   

Abstract

Although cognitive-behavioural therapy (CBT) is the treatment of choice for anxiety, its delivery needs to be adapted for individuals with traumatic brain injury (TBI). It also requires clients' active engagement for maximum benefit. This study was a pilot randomised controlled trial involving an anxiety treatment programme adapted for people with TBI, based on CBT and motivational interviewing (MI). Twenty-seven participants with moderate/severe TBI (aged 21-73 years, 78% males) recruited from a brain injury rehabilitation hospital were randomly allocated to receive MI + CBT (n = 9), non-directive counselling (NDC) + CBT (n = 10) and treatment-as-usual (TAU) (n = 8). CBT and MI were manualised and delivered in 12 weekly individual sessions. Primary outcome was self-reported anxiety symptoms assessed at baseline, at the end of NDC/MI and immediately following CBT. Assessment was conducted by assessors blinded to group assignment. Intention-to-treat analyses showed that the two active treatment groups demonstrated significantly greater anxiety reduction than TAU. Participants receiving MI showed greater response to CBT, in terms of reduction in anxiety, stress and non-productive coping, compared to participants who received NDC. The results provided preliminary support for the adapted CBT programme, and the potential utility of MI as treatment prelude. Longer follow-up data are required to evaluate the maintenance of treatment effects.

Entities:  

Mesh:

Year:  2012        PMID: 22632385     DOI: 10.1080/09602011.2012.678860

Source DB:  PubMed          Journal:  Neuropsychol Rehabil        ISSN: 0960-2011            Impact factor:   2.868


  8 in total

1.  Increased frequency of brain pathology in inmates of a high-security forensic institution: a qualitative CT and MRI scan study.

Authors:  Joachim G Witzel; Bernhard Bogerts; Kolja Schiltz
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2015-07-16       Impact factor: 5.270

2.  Motivational Interviewing as an Adjunct to Cognitive Behavior Therapy for Anxiety Disorders: A Critical Review of the Literature.

Authors:  Cameron L Randall; Daniel W McNeil
Journal:  Cogn Behav Pract       Date:  2017-08

3.  Does mental status impact therapist and patient communication in emergency department brief interventions addressing alcohol use?

Authors:  Brian Borsari; Timothy R Apodaca; Ali Yurasek; Peter M Monti
Journal:  J Subst Abuse Treat       Date:  2016-10-07

4.  Revisiting the neurofunctional approach: conceptualizing the core components for the rehabilitation of everyday living skills.

Authors:  Jo Clark-Wilson; Gordon Muir Giles; Doreen M Baxter
Journal:  Brain Inj       Date:  2014-08-25       Impact factor: 2.311

5.  Phone-based motivational interviewing to increase self-efficacy in individuals with phenylketonuria.

Authors:  Krista S Viau; Jessica L Jones; Maureen A Murtaugh; Lisa H Gren; Joseph B Stanford; Deborah A Bilder
Journal:  Mol Genet Metab Rep       Date:  2016-01-18

6.  A systematic review of anxiety interventions in stroke and acquired brain injury: Efficacy and trial design.

Authors:  Ho-Yan Yvonne Chun; Richard Newman; William N Whiteley; Martin Dennis; Gillian E Mead; Alan J Carson
Journal:  J Psychosom Res       Date:  2017-11-16       Impact factor: 3.006

Review 7.  Psychological Intervention in Traumatic Brain Injury Patients.

Authors:  Lizzette Gómez-de-Regil; Damaris F Estrella-Castillo; Julio Vega-Cauich
Journal:  Behav Neurol       Date:  2019-05-02       Impact factor: 3.342

8.  Evaluating a Novel Treatment Adapting a Cognitive Behaviour Therapy Approach for Sexuality Problems after Traumatic Brain Injury: A Single Case Design with Nonconcurrent Multiple Baselines.

Authors:  Elinor E Fraser; Marina G Downing; Kerrie Haines; Linda Bennett; John Olver; Jennie L Ponsford
Journal:  J Clin Med       Date:  2022-06-19       Impact factor: 4.964

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.